Ad
AGEN Stock - Agenus Stock Trading
About | Agenus Inc. (NASDAQ:AGEN)
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
Quote | Agenus Inc. (NASDAQ:AGEN)
| Last: | $4.95 |
|---|---|
| Change Percent: | 0.2% |
| Open: | $4.99 |
| Close: | $4.95 |
| High: | $5.1 |
| Low: | $4.81 |
| Volume: | 204,602 |
| Last Trade Date Time: | 09/06/2024 03:00:00 am |
News | Agenus Inc. (NASDAQ:AGEN)
-
2024-08-08 16:15:19 ET Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q2 2024 Earnings Call Aug 08, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Agenus (AGEN) Q2 2024 Earnings Call Transcript
-
2024-08-08 12:32:04 ET Agenus, Inc. (AGEN) Q2 2024 Earnings Conference Call August 8, 2024, 8:30 am ET Company Participants Zack Armen - Head, IR Garo Armen - Chairman & CEO Steven O'Day - CMO Christine Klaskin - VP, Finance Robin Taylor - CCO Tom...
Message Board Posts | Agenus Inc. (NASDAQ:AGEN)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI | whytestocks | investorshangout | 05/03/2023 6:35:51 PM |
| shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma | shalbyj | investorshangout | 04/25/2023 1:37:15 PM |
| whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti | whytestocks | investorshangout | 04/17/2023 12:00:59 PM |
| whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur | whytestocks | investorshangout | 03/27/2023 3:10:50 PM |
| whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week | whytestocks | investorshangout | 03/15/2023 8:20:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-08-08 16:15:19 ET Image source: The Motley Fool. Agenus (NASDAQ: AGEN) Q2 2024 Earnings Call Aug 08, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Agenus (AGEN) Q2 2024 Earnings Call Transcript
-
Augusta Gold Corp. (AUGG) is expected to report for Q2 2024 Amplitude Inc. (AMPL) is expected to report $-0.18 for Q2 2024 Cadiz Inc. (CDZI) is expected to report $-0.1 for Q2 2024 DAQO New Energy Corp. American Depositary Shares each representing five (DQ) is expected to report $-0.2...
-
Agenus Inc. (NASDAQ: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the publication of a seminal study in the prestigious Cancer Discovery , a journal of the American Association for Cancer Research, detailing the novel mechanism of action a...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...